Sumitomo Mitsui Trust Holdings, Inc. Repare Therapeutics Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $142 Billion
- Q3 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 249,215 shares of RPTX stock, worth $336,440. This represents 0.0% of its overall portfolio holdings.
Number of Shares
249,215
Previous 277,168
10.09%
Holding current value
$336,440
Previous $914,000
6.24%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding RPTX
# of Institutions
62Shares Held
35.4MCall Options Held
50KPut Options Held
300-
Bvf Inc San Francisco, CA10.3MShares$14 Million1.13% of portfolio
-
Blue Owl Capital Holdings LP New York, NY3.37MShares$4.55 Million3.82% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.32MShares$4.49 Million0.27% of portfolio
-
Chi Advisors LLC New York, NY2.97MShares$4.01 Million17.66% of portfolio
-
Versant Venture Management, LLC San Francisco, CA2.65MShares$3.57 Million23.86% of portfolio
About Repare Therapeutics Inc.
- Ticker RPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,937,800
- Market Cap $56.6M
- Description
- Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...